Roundview Capital’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.45M Sell
3,620
-12
-0.3% -$4.25K 0.08% 199
2026
Q1
$1.17M Buy
3,632
+175
+5% +$52.2K 0.07% 201
2025
Q4
$894K Buy
+3,457
New +$787K 0.06% 212
2015
Q4
Sell
-4,409
Closed -$227K 169
2015
Q3
$227K Buy
4,409
+56
+1% +$3.08K 0.1% 147
2015
Q2
$259K Hold
4,353
0.1% 137
2015
Q1
$263K Hold
4,353
0.1% 136
2014
Q4
$234K Hold
4,353
0.1% 140
2014
Q3
$205K Sell
4,353
-30,984
-88% -$1.4M 0.09% 122
2014
Q2
$1.57M Buy
+35,337
New +$1.39M 0.64% 50

Other funds holding MSGS

Roundview Capital's MSGS Position: Q2 2026 in Review

Roundview Capital reduced its Madison Square Garden (MSGS) stake by 0.33% in Q2 2026, selling an estimated $4.25K and leaving 3,620 shares worth $1.45M. The position accounts for 0.08% of the portfolio, ranked #199.

Roundview Capital first reported a position in MSGS in Q2 2014 and has held it in 9 quarters since. The position peaked at $1.57M in Q2 2014. 468 funds tracked by Wall St. Rank hold MSGS as of Q2 2026.

  • Roundview Capital held 3,620 shares of Madison Square Garden worth $1.45M as of Q2 2026.
  • Roundview Capital sold 12 Madison Square Garden shares in Q2 2026, an estimated $4.25K.
  • Madison Square Garden made up 0.08% of Roundview Capital's portfolio in Q2 2026, its #199 holding.
  • Roundview Capital first reported a position in Madison Square Garden in Q2 2014 and has held it in 9 quarters since.
  • Roundview Capital's Madison Square Garden position peaked at $1.57M in Q2 2014.
  • 468 funds tracked by Wall St. Rank held Madison Square Garden as of Q2 2026.

Based on Roundview Capital's 13F filing for Q2 2026, filed 30 Jul 2026.